Clinical News

SNOMED Diagnosis Code Update: July 2013

Professor Jonathan L Brown

In the October 2012 eNewsletter the Society was seeking the help of members to assist with the development of a SNOMED subset to allow the diagnosis field of a gastroenterology or hepatology electronic patient record to be populated. The request derived from the DH Informatics Directorate, Connecting for Health (CfH). In March 2013, CfH was superseded by the Health and Social Care Information Centre (HSCIC) and the project continues under their authority.

In the medical subspecialties, paediatrics, renal, rheumatology, respiratory and gastroenterology/hepatology have succeeded in creating a pilot data set and the next objective will be a phase of clinical evaluation. HSCIC is considering technical options for this and it is likely that volunteers will again be required. The BSG pilot data can be viewed below and was derived from the large Swansea database of clinical diagnosis fields combined with the C&B gastroenterology referral library and the Society list of exit examination conditions.

Nikki Simmonds and Jonathan Brown, assisted by a CfH terminologist, merged and contracted the data sets, removed redundancy and validated the SNOMED terms, The scope of the project was to allow a diagnosis field to be populated in 80% of outpatient consultations from a list of about 150 terms and not to produce an exhaustive list of all GI conditions. After evaluation it will become the preferred list of diagnoses for NHS messaging systems and our Society will need to consider a method for maintenance, development and ratification of new terms as clinical gastroenterology and electronic patient records continue to evolve. To this end, the other medical subspecialties have created information committees like the one we have just disbanded and so we will need to devise an alternative strategy if we are to keep up.

 

Golimumab approved for treating some forms of UC

Monday, 20 May 2013 09:58

On 15 May 2013, the U.S. Food and Drug Administration approved a new use for Simponi (golimumab) injection: treatment of adults with moderate to severe ulcerative colitis that is resistant (refractory) to prior treatment or requires continuous steroid therapy. Golimumab had previously been approved to treat rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis (arthritis affecting the joints in the spine and the pelvis). The press release provides full details.

Free access: ESPGHAN/ESPID evidence-based guidelines for the management of acute gastroenteritis in children in Europe

Monday, 15 April 2013 13:27

UEG has a new, free online course (2 hours) to help implement the ESPGHAN guidelines for the management of acute gastroenteritis. The course is also linked to a project (TEEN-AGE, Tutorial European Electronic Network on Acute Gastroenteritis) set up to measure the effectiveness of the e-learning intervention in physicians from different European countries. You can access the materials here.

IBD Registry Update

Monday, 11 February 2013 12:05

The first of three pilot sites for the UK IBD Registry started trialling the system on Tuesday 15th January. Launching later this year, the Registry will provide the first ever UK-wide repository of anonymised IBD patient data for prospective audit and research. By bringing this data together for the first time, the Registry Board aims to:

  • Provide local, regional & national data in order to better define the pattern of ulcerative colitis and Crohn's disease
  • Improve understanding of long term outcomes
  • Drive continuous improvement in patient care and access to care across the UK
  • Inform commissioning and service design
  • Support IBD research

Data can be entered either from existing databases, via a web portal, or by means of a new IBD Patient Management System (PMS), which has been developed by Chameleon Information Systems Ltd (suppliers of InfoFlex) under the guidance of Clinical Lead, Fraser Cummings. Fraser and his team have designed the PMS so that data can be easily entered during the consultation. The PMS will also provide real-time benefits such as a clinical summary of each patient at a glance, to save time leafing through paper notes, and work lists to support, for example, azathioprine monitoring, biologics follow-up or MDT meetings. Subject to local IT arrangements, the PMS can also be integrated with local PAS to further minimise data entry.

The pilot stage is due to run till March, and the launch of the Registry is scheduled for the BSG conference in June.

To find out more about the project, and how you can join, visit www.ibdregistry.org.uk or email This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Page 6 of 17